VCM
BTAI icon

Versant Capital Management’s BioXcel Therapeutics BTAI Stock Holding History

Versant Capital Management’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2
Closed -$173 – 1955
2023
Q2 		$173 Buy
+2
New +$173 ﹤0.01% 2002